Thursday, 28 March 2024


Singapore-based startup Aktivolabs raises $10 M to fuel global expansion

16 December 2022 | News

The funds will be utilized to grow data science capability

Singapore's Aktivolabs has secured a $10 million capital injection for a Series A round led by Mitsui & Co., Adaptive Capital Partners and SEEDS Capital, the investment arm of Enterprise Singapore.

The funds will be utilised to grow its data science capability, strengthen the existing team and portfolio of products and broaden its footprint in South East Asia (SEA), Europe and the US. The current product portfolio includes the Aktivo Score, Aktivo Mind, Glucolife and Goodbiome. HH Investments and Govin Capital have also participated in this round.

Cofounded by the late Professor David Lai, Gourab Mukherjee and Dr Meng-Han Kuok, Aktivolabs is a digital health-science company founded in 2017. It provides sustainable, evidence-based, individualized digital health solutions that help populations understand and manage their risk of chronic diseases. The platform harnesses real-time digital health data elements in a low-touch, cost-effective manner with measurable actuarial and actionable value to life and health insurers.

This investment will fuel Aktivolabs’ continued growth in its existing verticals, expanding geographical territories and client servicing capabilities. In addition, Aktivolabs will also utilsze part of the funds to develop the existing algorithm and data-analytics programme to enhance the efficiency and accuracy of predicting, preventing and self-management of chronic disease using digital biomarkers.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account